voice searchcamera search
Pirfenidone Tablets - 200 Mg Dosage, Effective Treatment For Idiopathic Pulmonary Fibrosis

Pirfenidone Tablets - 200 Mg Dosage, Effective Treatment For Idiopathic Pulmonary Fibrosis

Price: 270.00 INR / Box

(270.00 INR + 0% GST)

Get Latest Price

1 Pack Contains :

1

Minimum Pack Size :

10000

In Stock

In Stock

-10000+

Product Specifications

IndicationTreatment of idiopathic pulmonary fibrosis (IPF)
Pacakaging (Quantity Per Box)10 x 10 tablets per box
Salt CompositionPirfenidone
Origin of MedicineAllopathic
Dosage FormSolid
Drug TypeGeneric Drugs
IngredientsPirfenidone
Physical FormOther, Tablet
FunctionOther, Anti-fibrotic agent
Recommended ForAdults with idiopathic pulmonary fibrosis
DosageAs directed by physician
Dosage GuidelinesTake after meals to minimize gastrointestinal side effects
Suitable ForAdults
QuantityMultiple packaging sizes available
Storage InstructionsStore in a cool, dry place, away from direct sunlight
FOB PortMUMBAI
Payment TermsCash Advance (CA), Cash in Advance (CID), Cheque, Western Union, Others
Supply Ability1000 Per Day
Delivery Time01 Week
Sample AvailableYes
Sample PolicyFree samples available with shipping and taxes paid by the buyer
Packaging Details10X1X10TAB
Main Export Market(s)Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
CertificationsWHO-GMO
Unit TypePiece/Pieces
Packsize1
Product Unit10000 Piece/Pieces
Price Typefixed
CurrencyINR
Moq10000
Mop10000
ReturnableNo
Brand NamePirmax
Price270.00 INR (Approx.)
Stock Quantity50000
Minimum Order Quantity10000
Minimum Ordered Packs10000
GSTIN0%

Product Overview

Key Features

Pirfenidone IP 200 Mg

Company Details

This is to introduce ourselves as a professionally managed fast growing Pharmaceutical Company having more than Five Years of Manufacturing and Marketing experience. We are based at Mumbai in the State of Maharashtra. The Company has been accredited with ISO-9001:2008 and manufactures pharmaceutical formulations as per the guidelines of WHO. It is a (GMP Certified) Unit with total quality management and In-house Testing Laboratory. Our success is the result of focusing on our clients top priorities such as quality products, on-time delivery, competitive rates and unparalleled responsiveness. Johnlee manufactures more than 400 plus Pharmaceutical Formulation Products in the form of Tablets, Capsules, Dry syrup, Liquid Orals and Sustained Release Preparations. It is the Company constant and Company will also increasingly focus in high growth potential segments like Vaccines and Biogenetics. These new areas will add significant depth to the existing product pipeline. The proteasome has been validated as an important clinical target in cancer, and Johnlee Pharmaceuticals Pvt. Ltd. is developing next-generation proteasome inhibitors with a high degree of selectivity, with the goal of increasing therapeutic efficacy and reducing side effects.

Business Type

Exporter, Manufacturer, Supplier

Employee Count

20

Establishment

2005

Working Days

Monday To Saturday

GST NO

27AGKPJ8183H1ZY

Payment Mode

Cash Advance (CA)

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

GST

GST - 27AGKPJ8183H1ZY

3 RatingRating
Trusted SellerTrustedSeller

Mumbai, Maharashtra

Director

Mr Vikram K Jain

Members since

12 Years

Address

Office No.22 to 25, 2nd Floor, 72/78, Chapsey Building, Ladwadi, Shamaldas Gandhi Marg, Princess Street, Mumbai, Maharashtra, 400002, India

Report incorrect details

Compare With Similar Products

Buyer Feedback

3

3

Response Rate

91.05

Price Or Price Range

270.00 INR (Approx.)

1.5 USD ($) (Approx.)

2.73-2.86 USD ($) (Approx.)

Minimum Order Quantity

10000 Strip/Strips

100000 Strip/Strips

10 Box/Boxes

Indication

Treatment of idiopathic pulmonary fibrosis (IPF)

Treatment of idiopathic pulmonary fibrosis

Pacakaging (Quantity Per Box)

10 x 10 tablets per box

30 tablets

Salt Composition

Pirfenidone

Pirfenidone

Origin Of Medicine

Allopathic

Allopathic

Dosage Form

Solid

Oral tablet

Drug Type

Generic Drugs

Other, Prescription medicine

Generic Drugs

Ingredients

Pirfenidone

Pirfenidone

PIRFENIDONE

Physical Form

Other, Tablet

Other, Tablet

Tablets

Function

Other, Anti-fibrotic agent

Other, Anti-fibrotic agent

Other

Recommended For

Adults with idiopathic pulmonary fibrosis

Idiopathic Pulmonary Fibrosis (IPF)

Pirfenidone is used to treat a certain lung disease called idiopathic pulmonary fibrosis (IPF). This disease causes the lungs to get scarred and become stiff, making it hard to breathe.

Dosage

As directed by physician

As prescribed by physician

Missed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose.

Dosage Guidelines

Take after meals to minimize gastrointestinal side effects

Take with food as directed

Suitable For

Adults

Adults

Adults

Quantity

Multiple packaging sizes available

30 tablets (per box)

50 Boxes

Storage Instructions

Store in a cool, dry place, away from direct sunlight

Store below 25AdegC, in a dry place, protected from light

ROOM TEMP. 10 -30 C

FOB Port

MUMBAI

Adani port Mundra /Hajira Adani /Nhava-Sheva JNPT

Payment Terms

Cash Advance (CA), Cash in Advance (CID), Cheque, Western Union, Others

Cash in Advance (CID)

Supply Ability

1000 Per Day

25000 Per Day

100 Per Day

Delivery Time

01 Week

25 Days

2 Week

Sample Available

Yes

Yes

Sample Policy

Free samples available with shipping and taxes paid by the buyer

Free samples are available

Packaging Details

10X1X10TAB

1 STRIP OF 10 TABLET

2*15/BOX

Main Export Market(s)

Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Western Europe, Eastern Europe, Central America, Middle East, South America, Asia, North America, Australia, Africa

Certifications

WHO-GMO

WHO, GMP, ANVISA BRASIL, EUGMP, MHRA UK, TGA AUSTRALIA, NMPA CHINA and FDA INDIA

Main Domestic Market

All India

All India